Preclinical evaluation of cancer immune therapy using patient-derived tumor antigen-specific T cells in a novel xenograft platform.
Clin Transl Immunology
; 10(2): e1246, 2021.
Article
in En
| MEDLINE
| ID: mdl-33552509
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Clin Transl Immunology
Year:
2021
Document type:
Article
Country of publication: